Evidence map›Paper›PMID 42338029›Full record

ReviewMicrobiologyOpen2026

Synthetic Mirror Bacteria as a Frontier for Chiral Synthetic Biology and Biocontainment.

Mohammad Nazrul Islam Bhuiyan

Abstract readReview
In one paragraph

Review in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mohammad Nazrul Islam BhuiyanBCSIR Chattogram Laboratories, BCSIR, Chattogram, Bangladesh.ORCID 0000-0003-0175-6881

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chirality is a fundamental structural property of biological molecules that governs molecular recognition, enzymatic catalysis, and genetic information processing in living systems. Natural life exhibits a universal pattern of homochirality in which proteins are composed predominantly of l-amino acids, while nucleic acids contain d-sugars within their backbone structures. Advances in synthetic biology and chemical biology have stimulated growing interest in mirror biological systems that operate with inverted molecular chirality. In theory, mirror organisms would contain proteins composed of d-amino acids and nucleic acids built from l-sugars, forming a stereochemically inverted yet internally consistent biochemical framework that is largely incompatible with natural biological systems. This review examined the molecular foundations, engineering strategies, biosafety considerations, and ecological implications associated with the theoretical development of mirror bacteria. Particular emphasis is placed on the hierarchical organization of biological chirality and the stereochemical constraints that govern macromolecular folding, molecular recognition, and the processing of genetic information. Recent advances in the chemical synthesis of mirror proteins and mirror nucleic acids demonstrate that stereochemically inverted biomolecules can adopt stable structures and perform catalytic or informational functions. However, integrating these components into self replicating mirror cellular systems remains a major scientific challenge. Furthermore, the ecological interactions, evolutionary dynamics, and environmental persistence of mirror biological systems require careful biosafety evaluation and responsible governance. This review highlights key conceptual and technological challenges that must be addressed before mirror organisms can progress from theoretical constructs toward experimental feasibility.

Indexed as

BacteriaContainment of BiohazardsSynthetic BiologyAmino AcidsNucleic AcidsStereoisomerismAmino AcidsNucleic Acidsantimicrobial strategychiral medicinemirror bacteriamirror‐image antibioticsprophylactic agentssynthetic biology

Identifiers

PMID42338029
PMCPMC13291191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.